Trajectory of the circulating endothelial progenitor cell levels and their association with acute rejection after heart transplantation.
The endothelial progenitor cells (EPC) in non-transplant settings have reparative properties. However, their role in heart transplantation (HT) is not well defined. The aim of this study was to prospectively evaluate changes in EPC-levels in relation to post-HT rejection. There were 27 HT recipients who had EPC-levels quantified during 6 months after HT. The cellular (ACR) or an antibody-mediated rejection (AMR) were assessed by right ventricular endomyocardial biopsy. ACR and AMR were observed in 7(25.9%) and 6(22.2%) subjects respectively. The ACR status at 1-month post-HT did not differ with respect to EPC immediately post-HT. At 1 month post-HT in subjects without ACR or AMR, EPC-levels assessed at this time were significantly reduced compared to the measurements immediately post-HT (p=0.0003). During further observation, EPC levels were alike regardless of the rejection events. Nonetheless, greater changes (coefficient of variation) in EPClog (logarithmic transformation) were associated with the risk of AMR or ACR compared to those without any rejection event. (median [lower-upper quartile]) 15 [13-18] vs 8[5-13]; p=0.02) and (22[14-26] vs 8[5-13];p=0.01). The receiver operating characteristics curve showed that the coefficient of variation of EPClog of 12 was the optimal cut off value for the prediction of rejection (Area under the curve=0.85). Higher levels were associated with greater risk of ACR or AMR (p<0.005). Early reduction of EPC-levels was related to a lower risk of ACR or AMR. Greater changes of EPC-levels during observation were associated with a significantly higher risk of rejection.